This study examined the frequency and severity of sickle related pain, its impact on quality of life, and methods of coping for 25 children with sickle cell disease, aged 6-16 years. Subjects were matched with non-affected peers and asked to complete the Central Middlesex Hospital Children's Health Diary for four weeks.
the psychological impact of the disease should not be minimised, the current evidence also suggests high levels of successful adaptation and coping with the long term stress associated with sickle cell disease. 7 Sickle cell related pain has been classified as an acute recurrent pain syndrome.8 Pain crises are difficult to anticipate and are very variable in quality, duration, location, and severity. They may occur in any part of the body, although more frequently in the extremities and may be brief (less than one hour) or last for several days. The frequency and severity of pain crises is also extremely variable, with some patients reporting no pain crises, while others report frequent pain.9'-2
The aim of the present study was to examine the frequency and severity of all pain and illness events experienced by children and adolescents with sickle cell disease within the home and school environment, and compare these with a control group of non-affected children; to compare the frequency and severity of pain experienced by children with SS and SC disease; to determine whether children with sickle cell disease could discriminate between 'sickle' pain and other types of childhood pain; to assess the impact of different types of pain on their quality of life, and to describe their ways of coping with the pain.
Sickle cell disease is a group of recessively inherited blood diseases, in which the most common type is the homozygous SS state, although the interaction of sickle haemoglobin with other globin chain abnormalities also results in clinically significant but often milder disease, for example SC disease. The patients suffer from chronic haemolytic anaemia, recurrent painful crises, and end organ failure including asplenia, stroke, avascular necrosis, chronic lung disease, and chronic renal failure. The risk of unexpected death due to infection as a result of hyposplenism, and to acute vasoocclusive events, means that around 11 % of patients do not survive to adulthood.' There are around four million people with sickle cell disease globally,2 of whom over 6000 live in Britain and some 60 000 in North America. 3 Studies of the cognitive aspects of sickle cell disease have indicated small IQ deficits, which probably indicate subtle neurological effects due to subclinical cerebral infarcts. 4 Children with sickle cell disease were asked to rate whether they perceived the pain to be 'sickle related', or not. Mean pain, impact, and coping scores were computed for three types of pain: sickle pain, non-sickle pain, and controls' pain. Statistical comparison between these groups was carried out using one way analysis of variance (ANOVA) with a posteriori contrasts of all three groups using a modified LSD (Bonferroni) test with significance level at 0.05. In order to take into account within subject variation (for which the ANOVA does not control), additional comparisons were made between subjects with both sickle and nonsickle pain events, using paired significance tests. Other comparisons between children with sickle cell disease and controls used parametric or non-parametric tests depending on the type of distribution of specific variables. In general, more conservative non-parametric tests (Mann-Whitney U test) were preferred as the distribution of some outcome variables was not normal. One tailed tests of significance were used when the direction of effects was clearly predicted prior to data collection.
Results

GENERAL HEALTH
Results from daily ratings of 1400 diary days did not indicate significant differences between children with sickle cell disease and controls on 'quality of day' ratings and general health symptoms. Children with the disease rated their health as 'poor' for 4% of days compared with 2% for controls. However, control children tended to Mann-Whitney U test, p=0.036). However, 80% of children with a total summary pain score of greater than 3.0 were from the sickle cell disease group (fig 1) , including three children with SC disease. Overall children with For children with sickle cell disease the minority of pain events were perceived as not being related to the disease (27%). Out of 25 children with sickle cell disease, 13 children perceived none of their pain experience as being related to the disease. Nineteen separate sickle pain crises were identified from the 65 sickle pain event days. Twelve crises lasted for less than two days, one for three days, and six for 7-9 days. Only one of these crises resulted in attendance at hospital. For the children with sickle cell disease 175 days with a non-sickle pain compared with 182 days with a pain reported by controls. The proportional increase in pain events between those with sickle cell disease and controls is accurately accounted for by the sickle related pains (fig 2) . The combination of higher intensity and longer duration resulted in sickle related pains being significantly more severe than pain events reported by controls (table 2) .
Approximately 30% of sickle related pain was attributed to preceding events such as cold weather (14%), exercise (12%), and coughs (3%). Additionally, for one child, sickle related pain was clearly triggered by physical trauma such as falling over. There was an increased frequency of reported symptoms on the day before the beginning of a pain crisis. Altogether 75% of pain crises were preceded by a symptom indicating general poor health (for example, tiredness, cough/cold). There was also an increased frequency of particularly disturbed sleep (43%).
IMPACT OF SICKLE CELL DISEASE ON QUALITY OF LIFE
For all nine everyday activities recorded in the diary, the impact of pain events on everyday activity for children with sickle cell disease was much greater than for controls (table 3) . Children with sickle cell disease missed nearly 2% of school days due to pain events and were seven times more likely to miss school due to pain than controls. Similarly high rates of disruption were evident for being unable to take part in their favourite activities, doing sport, or seeing their friends. One child was unable to do sport for 26 out of 28 days. Chil Table 3 Comparison of children with sickle cell disease and controls: mean (SD) and median (range) number of days when pain prevented an everyday activity, over a 28 day period 'impacts' than controls (15.7 v 4.5). As with pain scores, six out of seven children with scores greater than 20 were from the sickle cell disease group. The impact of a pain event was much greater when the event was perceived as being related to sickle cell disease (table 2) . Nearly one third of sickle related pain days resulted in children not attending school whereas non-sickle related pain events rarely resulted in non-attendance at school. There was no difference between the impact of non-sickle pain for children with sickle cell disease and controls.
COPING WITH PAIN
For both groups, the most common response to coping with pain was to talk to a parent, and there was no difference in the frequency of discussing pain events with either siblings, friends, or teachers. For sickle related pain children with sickle cell disease were more likely to take medication (54% of pain days) than for non-sickle pain (9%) or compared with controls (6%) ( Sickle pain only once resulted in hospital admission despite it occurring on average one in 14 days. This estimate appears to be lower than the previously reported frequency of one in four days," but this difference was probably due to sampling differences. The Shapiro study only included subjects with at least three vasoocclusive crises over the previous year. According to Platt et al this would include only the most severe 5% of the sickle cell disease population.9 In our own sample, 48% had not had a vaso-occlusive crisis requiring hospital admission during the previous four years. Examination of the more severe children in our sample would broadly support Shapiro's much higher estimate.
CLINICAL IMPLICATIONS
Firstly, sickle pain, coped with at home, is a common experience for a large proportion of children with sickle cell disease and is likely to be under-reported in routine outpatient follow up appointments. The children in this study reported far fewer sickle pain events when attending the paediatric clinic and tended to minimise the impact of the disease on their daily lives. Children may be apprehensive about talking about their pain and/or other problems as this may be seen to increase the possibility of further blood tests or even a hospital admission.
Secondly, clinical management of sickle cell disease needs to take account of its variability, differences in coping styles, and the range of impact on daily life. Such variability indicates the importance of collaborative assessment involving the parent, child and clinician, before individually tailored advice is given. As nearly all sickle pain is dealt with at home, systematic assessment of current pain and coping methods needs to be focused on supporting successful pain management in the home environment. This can be done in two ways. Firstly, retrospective accounts of health events such as pain have very limited reliability." The use of a health diary for a brief period (2-4 weeks) may be extremely helpful in establishing the pattern, severity, and impact of sickle cell disease on the child's life. Secondly, the clinical team need to discuss with parents and children the ways that they have successfully coped with pain at home. Consultation can therefore become a process of supporting resilience as well as identifying clinical problems.
The identification of reliable triggers for sickle pain remains elusive. However physical trauma clearly triggered sickle pain for one child. Reported symptoms before onset of a sickle related pain (for example tiredness, cough/colds, and dehydration) were generally quite diverse, and would be difficult to use as predictors of a developing pain crisis. It is probable that minor ill health contributes to the risk of a pain crisis. It remains unknown whether psychological factors also play a part in increasing risk of sickle pain. More work is needed to develop a multivariate model that would have useful predictive power to enable patients to anticipate the beginning of sickle cell disease pain events.
Despite the resilience of children with sickle cell disease, this chronic disorder has a significant impact on the physical, psychological, educational, recreational, and social life of these children. A comprehensive health care service that aims to lessen this impact needs to be a genuinely multidisciplinary service that facilitates effective cooperation between health, education, and social agencies. However familiar this assertion may be, the provision of such services for many children with sickle cell disease still remains to be established.
